TLR2 and hepatocellular carcinoma: Exosomal HMGB1 from hepatocellular carcinoma cells promotes TIM-1+ regulatory B cell expansion via HMGB1-TLR2/4-MAPK pathways, which produce immunosuppressive cytokine IL-10 and can suppress CD8+ T cell activity